Effect of a technology-enabled respiratory in-reach service on reduction in the inappropriate use of oral corticosteroids (OCS) for suspected Airways Disease exacerbations (ADE) in an acute general hospital

Source: International Congress 2022 – COPD management: comorbidities, cohorts and real-world studies

Session: COPD management: comorbidities, cohorts and real-world studies
Session type: Thematic Poster
Number: 2106

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Al Helou (Birmingham (West Midlands), United Kingdom), G. Chellappah (Birmingham (West Midlands), United Kingdom), K. Jones (Birmingham (West Midlands), United Kingdom), P. Ellis (Birmingham (West Midlands), United Kingdom), A. Mansur (Birmingham (West Midlands), United Kingdom), R. Mukherjee (Birmingham (West Midlands), United Kingdom), P. Ellis (Solihull, United Kingdom). Effect of a technology-enabled respiratory in-reach service on reduction in the inappropriate use of oral corticosteroids (OCS) for suspected Airways Disease exacerbations (ADE) in an acute general hospital. 2106

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

• Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
• Expert interview: Physiological classification of lung function impairment
• Occupational exposures to respiratory diseases: A case-based discussion